Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06388109 · ClinicalTrials.gov registry record · NA
Positive Peers Intervention Clinical Trial
A NA study of HIV Infections, sponsored by MetroHealth Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 6
- Study locations
NCT06388109: Recruiting NA study of HIV Infections, sponsored by MetroHealth Medical Center.
NCT06388109 is a NA study of HIV Infections that is actively recruiting participants, run by MetroHealth Medical Center. The registered enrollment target is 250 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06388109, a NA study of HIV Infections, is actively recruiting participants, sponsored by MetroHealth Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 6
- Study locations
Study Summary
The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are associated with a) viral suppression, b) retention in care, and c) perceived HIV-related stigma? Participants will: * download the mobile app onto their personal smartphone * Use the mobile app as they find useful * complete online surveys at enrollment, 3 mo, 6, mo, 9 mo and 12 months.
Primary Outcome
Proportion of participants who have HIV viral load \<200 copies/ ml
Conditions Studied
Interventions
- OTHER Positive Peers mobile app
Study Locations (6)
Ohio
- Equitas Health - Cincinnati
- Equitas Health - Columbus
California
- Northeast Valley Health Corporation - Van Nuys
New Jersey
- Infectious Disease Practice- Rutgers University - Newark
Texas
- Thomas Street Clinic - Houston
Washington
- UW Madison Clinic at Harborview - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-06-03 |
| Est. Completion | 2027-11 |
| Phase | NA |
What NCT06388109 shows while recruiting
NCT06388109 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (44% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Positive Peers mobile app is the first listed.
NCT06388109 lists 6 locations in 5 states (Ohio, California, New Jersey).
Frequently Asked Questions
What is clinical trial NCT06388109 about?
NCT06388109 is a clinical study titled "Positive Peers Intervention Clinical Trial". The goal of this clinical trial is to learn if the Positive Peers mobile app intervention increases rates of viral suppression in young (13-34 y/o) persons with HIV. Does use of the Positive Peers app improve viral suppression among young minority persons with HIV? What user characteristics are ass...
What is the current status of trial NCT06388109?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-06-03. Estimated completion is 2027-11.
What conditions does trial NCT06388109 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT06388109?
The interventions under investigation include: Positive Peers mobile app (OTHER).
Who is sponsoring clinical trial NCT06388109?
This trial is sponsored by MetroHealth Medical Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06388109 being conducted?
This trial has 6 study locations across California, New Jersey, Ohio, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06388109's enrollment target sits among peer trials
250 139th of 542 higher than 396 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI